Funds holding CALIDI BIOTHERAPEUTICS INC
ISIN US3207034089 · United States
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 15.4K $
- Share of capital
- 3.3 % of 2.6M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 49,776 | 9.2K $ | 1.93 % | as of May 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 25,509 | 4.3K $ | 0.99 % | as of Jun 30, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 5,150 | 952.8 $ | 0.20 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 4,644 | 859.1 $ | 0.18 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 85,079 | +31.2 % |
| 2026Q2 | 4 | -1 | 64,871 | +30.2 % |
| 2026Q1 | 5 | 0 | 49,828 | -0.2 % |
| 2025Q4 | 5 | 49,932 |
Institutional managers
26 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 879,000 | 209.9K $ | as of Mar 31, 2026 |
| SABBY MANAGEMENT, LLC | 434,903 | 103.9K $ | as of Mar 31, 2026 |
| Warberg Asset Management LLC | 250,000 | 59.5K $ | as of Mar 31, 2026 |
| HighTower Advisors, LLC | 83,523 | 19.9K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 75,769 | 18 $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 63,019 | 15K $ | as of Mar 31, 2026 |
| RS CRUM INC. | 40,256 | 9.6K $ | as of Mar 31, 2026 |
| Arax Advisory Partners | 37,345 | 8.9K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 34,802 | 8.3K $ | as of Mar 31, 2026 |
| Belpointe Asset Management LLC | 19,921 | 4.8K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 17,758 | 4.2K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 10,133 | 2 $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 10,000 | 2.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 9,467 | 2.3K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 2,106 | 503 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,396 | 333 $ | as of Mar 31, 2026 |
| Apollo Management Holdings, L.P. | 1,042 | 249 $ | as of Mar 31, 2026 |
| Finepoint Capital LP | 1,042 | 249 $ | as of Mar 31, 2026 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,042 | 248 $ | as of Mar 31, 2026 |
| FMR LLC | 255 | 61 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 115 | 27 $ | as of Mar 31, 2026 |
| Tradewinds Capital Management, LLC | 101 | 25 $ | as of Mar 31, 2026 |
| Reyes Financial Architecture, Inc. | 100 | 24 $ | as of Mar 31, 2026 |
| CVA Family Office, LLC | 42 | 10 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 14 | 3 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding CALIDI BIOTHERAPEUTICS INC". https://titelia.com/en/stocks/calidi-biotherapeutics-inc-US3207034089